Dr Dora BlairOtorhinolaryngologist, Counties Manukau Health, Auckland, NZ
Dora Blair is a SET 3 ORLHNS trainee currently based at Counties Manukau DHB. She has worked at a number of North Island hospitals and has a passion for Paediatric ORL. She has presented at national and international conferences.
|
|
A Retrospective Review to Evaluate the Effect of a National HPV Vaccination Programme on the Incidence and Prevalence of Juvenile Onset Recurrent Respiratory Papillomatosis (JRRP)
D Blair, G van der Meer, E Toll, C Barber, M Neeff
Department of Otorhinolaryngology Starship Children’s Hospital, ADHB
Introduction: Juvenile onset recurrent respiratory papillomatosis (JRRP) is a rare disease characterized by benign, but aggressive and recurring laryngeal epithelial lesions. The responsible pathogen is the Human Papilloma Virus (HPV), with exposure thought to occur from maternal cervical HPV carriage. Despite low disease prevalence, this morbid condition frequently requires repeated surgical interventions to maintain airway patency and voice. HPV vaccination was introduced in 2008 for teenage girls in New Zealand (NZ) and is expected to indirectly reduce the incidence of JRRP.
Aims: This study aims to review compare disease patterns before and after the introduction of a national HPV vaccination programme.
Methods: A retrospective analysis of patients diagnosed with or treated for JRRP at Starship Children’s Hospital from 1st September 1998 to 1st September 2008 when the vaccination was introduced with those diagnosed after 1st September 2008.
Results: Analysis in progress. The effect of vaccination on JRRP will be presented.
D Blair, G van der Meer, E Toll, C Barber, M Neeff
Department of Otorhinolaryngology Starship Children’s Hospital, ADHB
Introduction: Juvenile onset recurrent respiratory papillomatosis (JRRP) is a rare disease characterized by benign, but aggressive and recurring laryngeal epithelial lesions. The responsible pathogen is the Human Papilloma Virus (HPV), with exposure thought to occur from maternal cervical HPV carriage. Despite low disease prevalence, this morbid condition frequently requires repeated surgical interventions to maintain airway patency and voice. HPV vaccination was introduced in 2008 for teenage girls in New Zealand (NZ) and is expected to indirectly reduce the incidence of JRRP.
Aims: This study aims to review compare disease patterns before and after the introduction of a national HPV vaccination programme.
Methods: A retrospective analysis of patients diagnosed with or treated for JRRP at Starship Children’s Hospital from 1st September 1998 to 1st September 2008 when the vaccination was introduced with those diagnosed after 1st September 2008.
Results: Analysis in progress. The effect of vaccination on JRRP will be presented.
